Tigecycline Opposes Bortezomib Effect on Myeloma Cells Decreasing Mitochondrial Reactive Oxygen Species Production

Multiple myeloma is an incurable plasma cell malignancy. Most patients end up relapsing and developing resistance to antineoplastic drugs, like bortezomib. Antibiotic tigecycline has activity against myeloma. This study analyzed tigecycline and bortezomib combination on cell lines and plasma cells f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences 2024-05, Vol.25 (9), p.4887
Hauptverfasser: Ramos-Acosta, Carlos, Huerta-Pantoja, Laura, Salazar-Hidalgo, Milton Eduardo, Mayol, Elsa, Jiménez-Vega, Selene, García-Peña, Pablo, Jordi-Cruz, Jenifeer, Baquero, Cristina, Porras, Almudena, Íñigo-Rodríguez, Belén, Benavente, Celina M, López-Pastor, Andrea R, Gómez-Delgado, Irene, Urcelay, Elena, Candel, Francisco Javier, Anguita, Eduardo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!